Integrated Referrals Following the March 2025 merger with Forcura and the June 24, 2025 integrated product launch, Medalogix now offers end-to-end referral management and start-of-care workflows for home health agencies. This creates a compelling opportunity to cross-sell to Forcura clients and to prospects seeking streamlined intake, referrals, and care initiation with AI-driven insights that improve outcomes.

Clinical AI Advantage Medalogix’s data science focus for home health and hospice, including Pulse Transitions and the data science model launched in 2024, enables predictive analytics to reduce rehospitalizations, optimize recertifications, and prevent avoidable LUPAs. Target agencies and payors pursuing value-based care with measurable ROI supported by proven AI-driven clinical decisions.

Platform Partnerships With a track record of partnerships and integrations, such as MatrixCare and Forcura, there is a clear path to expand integrations with additional EHR and post-acute platforms. This reduces adoption friction and enables co-selling opportunities with partner ecosystems to reach more home health and hospice providers.

Post-Acute Growth Medalogix is positioning to build a transformative post-acute care technology platform with private equity backing and a growing revenue base. This signals opportunity to target mid-market agencies and payors seeking modern, scalable solutions for population health, workflow optimization, and outcome-driven care across the post-acute continuum.

Credible Validation Industry recognition from Harvard Business Review, HIMSS, Fierce Healthcare, and Becker’s Hospital Review provides strong credibility for ROI storytelling. Leverage these validations in outreach, case studies, and ROI models to shorten sales cycles when engaging prospective home health and hospice clients.